Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinoma

Hepatology

Volumn 52, Issue 5, 2010, Pages 1690-1701

  Chen, Chian Feng ^a,c   Hsu, En Chi ^a   Lin, Kuen Tyng ^a   Tu, Pang Hsien ^a   Chang, Hung Wei ^a,d   Lin, Chin Hui ^c   Chen, Yann Jang ^c   Gu, De Leung ^c   Lin, Chi Hung ^c   Wu, Jer Yuarn ^a,b   Chen, Yuan Tsong ^a,b   Hsu, Ming Ta ^c   Jou, Yuh Shan ^a,d  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; STAT3 PROTEIN;

AMPLICON; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; FIBRONECTIN TYPE III DOMAIN CONTAINING 3B; GENE; GENE AMPLIFICATION; GENE DELETION; GENE DOSAGE; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENE SILENCING; GENOME; GENOMICS; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOLUTE CARRIER FAMILY 29 MEMBER 2A; TUMOR GENE; UPREGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; COLONY-FORMING UNITS ASSAY; GENE KNOCKDOWN TECHNIQUES; GENES, NEOPLASM; GENOME; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICE; MICE, NUDE; MUTATION; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA INTERFERENCE;

EID: 78049487254     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23847     Document Type: Article

References (28)

1. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A 1987; 84: 6899-6903.
2. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, et al. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias. Blood 1994; 84: 2431-2435.
3. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, et al. Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 1995; 85: 3416-3422.
4. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-1812.
5. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008; 455: 1069-1075.
6. Fox EJ, Salk JJ, Loeb LA. Cancer genome sequencing-an interim analysis. Cancer Res 2009; 69: 4948-4950.
7. Zhao X, Li C, Paez JG, Chin K, Janne PA, Chen TH, et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. Cancer Res 2004; 64: 3060-3071.
8. Volchenboum SL, Li C, Li S, Attiyeh EF, Reynolds CP, Maris JM, et al. Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis. Cancer Res 2009; 69: 4143-4149.
9. Pan WH, Fann CS, Wu JY, Hung YT, Ho MS, Tai TH, et al. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered 2006; 61: 27-30.
10. Li C, Wong WH. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 2001; 98: 31-36.
11. Wang F, Denison S, Lai JP, Philips LA, Montoya D, Kock N, et al. Parkin gene alterations in hepatocellular carcinoma. Genes Chromosomes Cancer 2004; 40: 85-96.
12. Chen CF, Yeh SH, Chen DS, Chen PJ, Jou YS. Molecular genetic evidence supporting a novel human hepatocellular carcinoma tumor suppressor locus at 13q12.11. Genes Chromosomes Cancer 2005; 44: 320-328.
13. Lamba JK, Chen X, Lan LB, Kim JW, Wei Wang X, Relling MV, et al. Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans. Pharmacogenet Genomics 2006; 16: 415-427.
14. Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ, Jou YS. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 2007; 35: D727-D731.
15. Tominaga K, Kondo C, Johmura Y, Nishizuka M, Imagawa M. The novel gene fad104, containing a fibronectin type III domain, has a significant role in adipogenesis. FEBS Lett 2004; 577: 49-54.
16. Nishizuka S, Ramalingam S, Spurrier B, Washburn FL, Krishna R, Honkanen P, et al. Quantitative protein network monitoring in response to DNA damage. J Proteome Res 2008; 7: 803-808.
17. Zhang L, Ma QY, Meng XK, Li K, Cheng J. Cloning and screening of transregulated genes of NS5ABP37 by SSH. J Xi'an Jiaotong Univ (Med Sci) 2009; 30: 399-402.
18. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res 2008; 68: 6779-6788.
19. Zhang X, Liu S, Hu T, He Y, Sun S. Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. HEPATOLOGY 2009; 50: 490-499.
20. Lu Y, Yi Y, Liu P, Wen W, James M, Wang D, et al. Common human cancer genes discovered by integrated gene-expression analysis. PLoS One 2007; 2: e1149.
21. Kikuchi LO, Paranagua-Vezozzo DC, Chagas AL, Mello ES, Alves VA, Farias AQ, et al. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma. J Clin Gastroenterol 2009; 43: 191-195.
22. Hartmann E, Fernandez V, Moreno V, Valls J, Hernandez L, Bosch F, et al. Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue. J Clin Oncol 2008; 26: 4966-4972.
23. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, Young JD. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 2004; 447: 735-743.
24. King AE, Ackley MA, Cass CE, Young JD, Baldwin SA. Nucleoside transporters: from scavengers to novel therapeutic targets. Trends Pharmacol Sci 2006; 27: 416-425.
25. Govindarajan R, Endres CJ, Whittington D, LeCluyse E, Pastor-Anglada M, Tse CM, et al. Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes. Am J Physiol Gastrointest Liver Physiol 2008; 295: G570-G580.
26. Mathews CK. DNA precursor metabolism and genomic stability. FASEB J 2006; 20: 1300-1314.
27. Adair TH. Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol 2005; 289: R283-R296.
28. Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. HEPATOLOGY 2008; 48: 2047-2063.